OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
3
Results
Show all
Save search
Copy query
Show results for
Unknown
(3)
Publication Date
Release Date
2021
(2)
2024
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Durvalumab and guadecitabine in advanced clear cell renal cell carcinoma: results from the phase Ib/II study BTCRC-GU16-043.
Not available
S-EPMC10834488
|
biostudies-literature
Cite
Mapping the immune environment in clear cell renal carcinoma by single-cell genomics.
Not available
S-EPMC7840906
|
biostudies-literature
Cite
CD177 modulates the function and homeostasis of tumor-infiltrating regulatory T cells.
Not available
S-EPMC8486774
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
